financetom
Business
financetom
/
Business
/
Ares Management Insider Bought Shares Worth $1,413,300, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Ares Management Insider Bought Shares Worth $1,413,300, According to a Recent SEC Filing
Mar 14, 2025 12:42 AM

03:16 AM EDT, 03/14/2025 (MT Newswires) -- Ashish Bhutani, Director, on March 11, 2025, executed a purchase for 10,000 shares in Ares Management ( ARES ) for $1,413,300. Following the Form 4 filing with the SEC, Bhutani has control over a total of 22,905 Class A common shares of the company, with 22,905 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1176948/000162828025012703/xslF345X05/wk-form4_1741911248.xml

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Chevron misses earnings estimate as refining posts first loss in four years
Chevron misses earnings estimate as refining posts first loss in four years
Jan 31, 2025
Jan 31 (Reuters) - Chevron Corp ( CVX ) reported fourth-quarter earnings below Wall Street estimates on Friday as weak margins pushed its refining business into a loss for the first time since 2020. The second-largest U.S. oil producer posted total earnings of $3.24 billion for the three months ended Dec. 31, up from $2.26 billion in the same period...
Chevron misses earnings estimate as refining posts first loss in four years
Chevron misses earnings estimate as refining posts first loss in four years
Jan 31, 2025
(Reuters) - Chevron Corp ( CVX ) reported fourth-quarter earnings below Wall Street estimates on Friday as weak margins pushed its refining business into a loss for the first time since 2020. The second-largest U.S. oil producer posted total earnings of $3.24 billion for the three months ended Dec. 31, up from $2.26 billion in the same period last year....
Top Indian drugmaker Sun Pharma's Q3 profit beats estimates on strong local sales
Top Indian drugmaker Sun Pharma's Q3 profit beats estimates on strong local sales
Jan 31, 2025
By Kashish Tandon and Rishika Sadam HYDERABAD/BENGALURU Jan 31 (Reuters) - Sun Pharmaceutical, India's largest drugmaker by revenue, reported a bigger-than-expected quarterly profit on Friday, aided by strong sales in the domestic market. The Mumbai-based firm's consolidated net profit rose 15% to 29.03 billion rupees ($335.3 million) in the third quarter, beating analysts' average estimate of 28.81 billion rupees, according...
Orsted replaces CEO as offshore wind industry struggles
Orsted replaces CEO as offshore wind industry struggles
Jan 31, 2025
* Mads Nipper to step down as CEO * Deputy CEO Errboe takes the helm with immediate effect * Shares are down 83% from 2021 peak * Orsted has been hit by soaring costs and impairments (Rewrites with more quotes, analyst, background, updates shares) By Stine Jacobsen and Isabelle Yr Carlsson COPENHAGEN, Jan 31 (Reuters) - Orsted Chief Executive Mads...
Copyright 2023-2026 - www.financetom.com All Rights Reserved